Furthermore, MDA-MB-231 and MCF-7 treated with combined concentrations of genistein and SFN resulted in the decreased expression of HDAC2, HDAC3, KLF4, and hTERT, suggesting the alterations of epigenetic mechanisms in breast cancer cells [89]. The gene discussed is HDAC2; the disease is breast carcinoma.